Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 2/2019

01-03-2019 | Original Article

Disease burden of fractures among patients with osteoporosis in Japan: health-related quality of life, work productivity and activity impairment, healthcare resource utilization, and economic costs

Authors: Saeko Fujiwara, Xiahong Zhao, Cheryl Teoh, Dena H. Jaffe, Yurie Taguchi

Published in: Journal of Bone and Mineral Metabolism | Issue 2/2019

Login to get access

Abstract

Osteoporosis remains undertreated in Japan, and bone fractures are the most frequent complications imposing heavy burden on individuals and the community. This paper investigates the clinical and economic burden of fractures among osteoporosis patients in Japan. The Japan National Health and Wellness Survey 2012–2014 database was used for analysis. Respondents aged ≥ 50 years and indicated a physician diagnosis of osteoporosis (N = 1107) were categorized into three subgroups: no prior fracture (N = 693), single fracture (N = 242), and multiple (≥ 2) fractures (N = 172). Health-related quality of life (HRQoL), work productivity and activity impairment, healthcare resource utilization and associated direct and indirect costs were compared across three fracture subgroups adjusting for respondents’ sociodemographic and clinical characteristics using generalized linear regression models. The estimated fracture prevalence among respondents with osteoporosis who were ≥ 50 years was 37.4%, of whom 41.5% had multiple fractures. Relative to osteoporosis respondents with no fracture and with single fracture, those with multiple fractures reported significant higher disability in HRQoL, more healthcare resource utilization, and were associated with higher direct costs. Improved treatment of fractures among osteoporosis patients is necessary and may help reduce the clinical and economic burden in this osteoporosis population.
Appendix
Available only for authorised users
Literature
7.
go back to reference Martin AR, Sornay-Rendu E, Chandler JM et al (2002) The impact of osteoporosis on quality-of-life: the OFELY cohort. Bone 31:32–36CrossRefPubMed Martin AR, Sornay-Rendu E, Chandler JM et al (2002) The impact of osteoporosis on quality-of-life: the OFELY cohort. Bone 31:32–36CrossRefPubMed
8.
go back to reference Cook DJ, Guyatt GH, Adachi JD et al (1993) Quality of life issues in women with vertebral fractures due to osteoporosis. Arthritis Rheum 36:750–756CrossRefPubMed Cook DJ, Guyatt GH, Adachi JD et al (1993) Quality of life issues in women with vertebral fractures due to osteoporosis. Arthritis Rheum 36:750–756CrossRefPubMed
9.
go back to reference Borgström F, Lekander I, Ivergård M et al (2013) The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)—quality of life during the first 4 months after fracture. Osteoporos Int J Establ Results Coop Eur Found Osteoporos Natl Osteoporos Found USA 24:811–823. https://doi.org/10.1007/s00198-012-2240-2 CrossRef Borgström F, Lekander I, Ivergård M et al (2013) The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)—quality of life during the first 4 months after fracture. Osteoporos Int J Establ Results Coop Eur Found Osteoporos Natl Osteoporos Found USA 24:811–823. https://​doi.​org/​10.​1007/​s00198-012-2240-2 CrossRef
15.
20.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed
21.
go back to reference Morisky DE, Ang A, Krousel-Wood M, Ward HJ (2008) Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens Greenwich Conn 10:348–354CrossRef Morisky DE, Ang A, Krousel-Wood M, Ward HJ (2008) Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens Greenwich Conn 10:348–354CrossRef
22.
go back to reference Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21:271–292CrossRefPubMed Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21:271–292CrossRefPubMed
23.
go back to reference Maruish ME (2011) User’s manual for the SF-36v2 Health Survey, 3rd edn. QualityMetric Incorporated, Lincoln Maruish ME (2011) User’s manual for the SF-36v2 Health Survey, 3rd edn. QualityMetric Incorporated, Lincoln
24.
go back to reference Reilly MC, Zbrozek AS, Dukes EM (1993) The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics 4:353–365CrossRefPubMed Reilly MC, Zbrozek AS, Dukes EM (1993) The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics 4:353–365CrossRefPubMed
25.
go back to reference Lofland JH, Pizzi L, Frick KD (2004) A review of health-related workplace productivity loss instruments. PharmacoEconomics 22:165–184CrossRefPubMed Lofland JH, Pizzi L, Frick KD (2004) A review of health-related workplace productivity loss instruments. PharmacoEconomics 22:165–184CrossRefPubMed
30.
go back to reference Corp IBM (2015) IBM SPSS statistics for windows. IBM Corp., Armonk Corp IBM (2015) IBM SPSS statistics for windows. IBM Corp., Armonk
34.
go back to reference Pinheiro MM, dos Reis Neto ET, Machado FS et al (2010) Risk factors for osteoporotic fractures and low bone density in pre and postmenopausal women. Rev Saude Publica 44:479–485CrossRefPubMed Pinheiro MM, dos Reis Neto ET, Machado FS et al (2010) Risk factors for osteoporotic fractures and low bone density in pre and postmenopausal women. Rev Saude Publica 44:479–485CrossRefPubMed
37.
go back to reference Delmas PD, Rizzoli R, Cooper C, Reginster J-Y (2005) Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation. Osteoporos Int J Establ Results Coop Eur Found Osteoporos Natl Osteoporos Found USA 16:1–5. https://doi.org/10.1007/s00198-004-1813-0 CrossRef Delmas PD, Rizzoli R, Cooper C, Reginster J-Y (2005) Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation. Osteoporos Int J Establ Results Coop Eur Found Osteoporos Natl Osteoporos Found USA 16:1–5. https://​doi.​org/​10.​1007/​s00198-004-1813-0 CrossRef
39.
go back to reference Caliri A, De FL, Bagnato GL, Bagnato GF (2007) Osteoporotic fractures: mortality and quality of life. Panminerva Med 49:21–27PubMed Caliri A, De FL, Bagnato GL, Bagnato GF (2007) Osteoporotic fractures: mortality and quality of life. Panminerva Med 49:21–27PubMed
Metadata
Title
Disease burden of fractures among patients with osteoporosis in Japan: health-related quality of life, work productivity and activity impairment, healthcare resource utilization, and economic costs
Authors
Saeko Fujiwara
Xiahong Zhao
Cheryl Teoh
Dena H. Jaffe
Yurie Taguchi
Publication date
01-03-2019
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 2/2019
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-018-0916-1

Other articles of this Issue 2/2019

Journal of Bone and Mineral Metabolism 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.